Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies
Key Takeaways
- Tumor lysis syndrome is a rapid electrolyte and renal emergency most associated with highly proliferative or treatment-sensitive cancers.
- Hypercalcemia of malignancy can cause dehydration, constipation, weakness, confusion, dysrhythmias, and coma if not treated promptly.
- SIADH causes dilutional hyponatremia that may present with headache, nausea, confusion, seizures, or decreased level of consciousness.
- Nursing actions emphasize early lab review, hydration or fluid restriction as ordered, cardiac and neurologic monitoring, medication administration, and escalation.
- Patient education should identify urgent symptoms and reinforce lab monitoring before and after high-risk therapy.
Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies
Metabolic emergencies are common testable emergencies because they require fast recognition and disciplined monitoring. Symptoms often look nonspecific at first: fatigue, nausea, poor intake, constipation, muscle cramps, headache, confusion, weakness, or decreased urine output. The RN should connect these findings with diagnosis, treatment timing, renal function, hydration status, and recent laboratory values.
Tumor Lysis Syndrome
Tumor lysis syndrome, or TLS, occurs when malignant cells break down rapidly and release intracellular contents. It is most associated with acute leukemias, high-grade lymphomas, bulky disease, high tumor burden, high chemosensitivity, and impaired kidney function. TLS can occur after chemotherapy, targeted therapy, steroids, radiation, or rarely before treatment.
| TLS change | Nursing concern |
|---|---|
| Hyperkalemia | Dysrhythmias, weakness, cardiac arrest |
| Hyperphosphatemia | Hypocalcemia and renal injury |
| Hypocalcemia | Tetany, seizures, prolonged QT, cramps |
| Hyperuricemia | Acute kidney injury |
| Rising creatinine | Reduced clearance and worsening electrolyte risk |
Prevention and management may include aggressive IV hydration, strict intake and output, daily weights, telemetry for high-risk patients, frequent labs, allopurinol or rasburicase as ordered, and avoidance of potassium or phosphate loads when directed. Report rising potassium, phosphorus, uric acid, creatinine, decreased urine output, muscle twitching, seizure, chest pain, or dysrhythmia immediately. Do not administer calcium for asymptomatic TLS-related hypocalcemia unless directed, because calcium-phosphate precipitation may worsen renal injury.
Hypercalcemia of Malignancy
Hypercalcemia can result from bone metastases, tumor secretion of parathyroid hormone-related peptide, myeloma bone disease, dehydration, or other mechanisms. Symptoms may include thirst, polyuria, constipation, anorexia, nausea, vomiting, muscle weakness, bone pain, shortened QT interval, confusion, lethargy, and coma. Older adults may present mainly with falls or mental status change.
Nursing care includes assessing volume status, mental status, bowel pattern, fall risk, cardiac rhythm if severe, and renal function. Anticipate isotonic IV fluids, bisphosphonate or denosumab therapy, calcitonin for rapid temporary effect, antiemetics, mobility support, and treatment of the malignancy. Teach patients to report worsening confusion, severe constipation, inability to drink, vomiting, palpitations, or weakness. Unless contraindicated, hydration is often central, but the nurse must monitor for fluid overload in patients with cardiac or renal disease.
SIADH and Hyponatremia
Syndrome of inappropriate antidiuretic hormone secretion, or SIADH, causes water retention and dilutional hyponatremia. It is classically associated with small cell lung cancer but can also occur with CNS disease, pulmonary disorders, medications, pain, nausea, and some treatments. Symptoms depend on sodium level and speed of decline. Early signs include headache, nausea, cramps, fatigue, and mild confusion. Severe or rapid hyponatremia can cause seizures, coma, respiratory arrest, or death.
RN actions include seizure precautions when indicated, neurologic checks, fall precautions, accurate intake and output, daily weights, and lab trend review. Implement fluid restriction only as ordered and explain it clearly because patients may be thirsty or confused. Hypertonic saline, salt tablets, loop diuretics, vasopressin receptor antagonists, or ICU monitoring may be ordered depending on severity. Sodium must be corrected carefully; the nurse should not encourage rapid unsupervised sodium loading.
Escalation and Education
Escalate urgently for seizure, new confusion, severe weakness, chest pain, palpitations, syncope, tetany, decreased urine output, severe vomiting, or marked lab abnormalities. Patients starting high-risk treatment should understand why labs may be checked frequently and why hydration, urine measurement, and medication adherence matter. Use teach-back: what number to call, which symptoms are urgent, and whether they should go directly to emergency care.
Monitoring Patterns
For TLS risk, nurses should compare current labs with baseline rather than viewing one value in isolation. A potassium that is still within range but rising quickly may be more concerning than a stable mild abnormality. For hypercalcemia, trend mental status, bowel function, hydration, urine output, creatinine, and cardiac symptoms; severe constipation or new confusion can be clinically important even before the patient looks critically ill. For SIADH, neurologic change is often the warning sign that the sodium level is affecting the brain.
Handoff should include the suspected syndrome, most recent labs, rate of change, fluids or restrictions ordered, medications given, telemetry status, seizure precautions, and family teaching completed.
Which laboratory pattern is most consistent with tumor lysis syndrome?
A patient with lung cancer and SIADH becomes increasingly confused and has a seizure. What is the priority nursing action?
Which symptom cluster best suggests hypercalcemia of malignancy?